Related Experiment Video

Updated: Aug 10, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

[Clinical role of cell cycle regulators in androgen-dependent cancer cell growth]

Y Hashimoto1, H Akita, A Iizuka

  • 1Department of Urology, Nagoya City University, Medical School.

Hinyokika Kiyo. Acta Urologica Japonica
|February 24, 2001
PubMed

Insights

Androgen depletion causes G1 arrest in androgen-dependent cancer cells by downregulating cyclin D1 and upregulating p27. Cell cycle regulators are key targets in anti-androgen therapy response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Context:

  • Androgen deprivation therapy is a cornerstone treatment for prostate cancer.
  • Understanding the initial cellular response to androgen withdrawal is crucial for optimizing treatment strategies.

Purpose:

  • To investigate the functional and quantitative changes in cell cycle regulators following androgen depletion.
  • To elucidate the interaction between the androgen receptor (AR) and cell cycle regulators in response to anti-androgen therapy.

Summary:

  • Androgen depletion in an androgen-dependent cancer cell line (SC-3) induced G1 cell cycle arrest, confirmed by Fluorescence Activated Cell Sorting (FACS).
  • This arrest was associated with decreased cyclin D1 protein levels and increased messenger RNA (mRNA) and protein levels of the cyclin-dependent kinase inhibitor (CKI) p27.
  • Conversely, cyclin E enhanced the transactivation activity of the human androgen receptor (AR) in the presence of dihydrotestosterone (DHT).

Impact:

  • Identifies cell cycle regulators as critical targets in the early response of androgen-dependent cancers to androgen depletion.
  • Highlights the role of cell cycle regulators in modulating the transcriptional activity of the androgen receptor.
  • Provides insights into potential therapeutic strategies targeting cell cycle pathways in prostate cancer treatment.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...